Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 17, 2017 - Issue 4
Submit an article Journal homepage
1,456
Views
9
CrossRef citations to date
0
Altmetric
Editorial

Beyond platinum treatment for NSCLC: what does the future hold?

Mariacarmela SantarpiaMedical Oncology Unit, Department of Human Pathology ‘G. Barresi’, University of Messina, Messina, ItalyCorrespondence[email protected]
View further author information
,
Niki KarachaliouInstitute of Oncology Rosell (IOR), University Hospital Sagrat Cor, Barcelona, SpainView further author information
&
Rafael RosellInstitute of Oncology Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain;Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain;Cellular and Molecular Biology Laboratory, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Barcelona, SpainView further author information
Pages 293-295 | Received 04 Nov 2016, Accepted 25 Jan 2017, Published online: 08 Feb 2017

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mariacarmela Santarpia, Alessia Liguori, Niki Karachaliou, Maria Gonzalez-Cao, Maria Grazia Daffinà, Alessandro D’Aveni, Grazia Marabello, Giuseppe Altavilla & Rafael Rosell. (2017) Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy. Lung Cancer: Targets and Therapy 8, pages 109-125.
Read now

Articles from other publishers (8)

Xiaoju Chen, Ling Luo, Yanyan Lu, Ye Qiu, Jie Liang, Yulin Chen, Yufang Ning & Bixun Li. (2023) Construction of IMMS Containing Multi-site Liposomes for Dynamic Monitoring of Blood CTC in Patients with Osimertinib-resistant Non-small-cell Lung Cancer and its Mechanism. Anti-Cancer Agents in Medicinal Chemistry 23:6, pages 676-686.
Crossref
Sofia Lampaki, Giannis Mountzios, Vassilis Georgoulias, Aggeliki Rapti, Ioannis Xanthakis, Sofia Baka, Dimitrios Mavroudis, Epaminondas Samantas, Elias Athanasiadis, Flora Zagouri, Andriani Charpidou, Alvertos Somarakis, Christina Papista, Aristeidis Nikolaou, Eleftheria Anastasopoulou, Zoe Paparepa & Konstantinos N Syrigos. (2022) Real-world management patterns in EGFR -mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece . Future Oncology 18:28, pages 3151-3164.
Crossref
Sanchareeka Dey, Adnin Ashrafi, Chantal Vidal, Nivesh Jain, Sarada Preeta Kalainayakan, Poorva Ghosh, Parinaz Sadat Alemi, Narges Salamat, Purna Chaitanya Konduri, Jung-whan Kim & Li Zhang. (2022) Heme Sequestration Effectively Suppresses the Development and Progression of Both Lung Adenocarcinoma and Squamous Cell Carcinoma. Molecular Cancer Research 20:1, pages 139-149.
Crossref
Wei Gao, Jinxiao Liang, Yiru Ye, Jinlan Lu, Tongtong Lin, Na Wang, Jingyin Dong & Jianping Pan. (2020) FUT4siRNA augments the chemosensitivity of non-small cell lung cancer to cisplatin through activation of FOXO1-induced apoptosis. BMC Cancer 20:1.
Crossref
Jing Cong, Yuguang Zhang, Yadong Xue, Chuantao Zhang, Mingjin Xu, Dong Liu, Ruiyan Zhang & Hua Zhu. (2020) A Pilot Study: Changes of Intestinal Microbiota of Patients With Non-small Cell Lung Cancer in Response to Osimertinib Therapy. Frontiers in Microbiology 11.
Crossref
Sarada Preeta Kalainayakan, Poorva Ghosh, Sanchareeka Dey, Keely E. Fitzgerald, Sagar Sohoni, Purna Chaitanya Konduri, Massoud Garrossian, Li Liu & Li Zhang. (2019) Cyclopamine tartrate, a modulator of hedgehog signaling and mitochondrial respiration, effectively arrests lung tumor growth and progression. Scientific Reports 9:1.
Crossref
Abdul Rahman Jazieh, Turki M Fayea, Mervat Mahrous, Tarek Darwish, Essam Fawzi, Ashwaq A Alolayan, Nagham Sheblaq, Mohammed Alkaiyat & Yosra Ali. (2018) Erlotinib in Patients with Advanced Non-small Cell Lung Cancer in Middle Eastern Population. Journal of Immunotherapy and Precision Oncology 1:1, pages 19-25.
Crossref
Qiang Zhang, Bin Zhang, Leina Sun, Qingna Yan, Yu Zhang, Zhenfa Zhang, Yanjun Su & Changli Wang. (2018) Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation. Acta Biochimica et Biophysica Sinica 50:8, pages 748-756.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.